A mutiple -dose, dose-escalation phase I study on the tolerability and safety of recombinant erythropoiesis stimulating protein ( CHO cell ) injection in patients with chronic kidney disease with anemia
Latest Information Update: 10 Jun 2016
At a glance
- Drugs Darbepoetin alfa (Primary) ; Darbepoetin alfa (Primary)
- Indications Anaemia
- Focus Adverse reactions
- Sponsors 3SBio
- 02 Jun 2016 Status changed from recruiting to completed.
- 02 Dec 2013 New trial record